Ironwood is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines targeting important therapeutic needs. Our goal is to build the next great pharmaceutical company—an outstanding business that will thrive and endure well beyond our lifetimes and generate substantial returns for our shareholders.

Press Releases

01.04.2012
Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement

01.03.2012
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

11.07.2011
Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update

11.02.2011
Ironwood Pharmaceuticals to Present at Credit Suisse 2011 Healthcare Conference

10.31.2011
Ironwood Pharmaceuticals to Host Third Quarter 2011 Investor Update Call

View all releases »




Current Prices
Quotes delayed 20 minutes
IRWD NASDAQ $14.09   - 0.03


2011 Proxy Statement | 04.27.2011
View/Download PDF Version
2010 Annual Report | 03.30.2011
View/Download PDF Version


Ironwood IR contact
Susan Brady
Corporate Communications
T 617.621.8304
E ir@ironwoodpharma.com
Auditors
Ernst & Young
200 Clarendon Street
Boston, MA 02116
T 617.266.2000
Transfer agent
Computershare Investor Services
P.O.Box 43078
Providence, RI 02940
T 800.662.7232
www.computershare.com